A Prospective Study of the Quality of Life of Patients with Stress Incontinence before and after a Transobturator Tape (TOT) Procedure-Preliminary Report.
TOT procedure
quality of life
stress urinary incontinence
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
31
08
2021
revised:
24
09
2021
accepted:
29
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
epublish
Résumé
Urinary incontinence (UI) is a significant social problem. The latest figures show that it affects as many as 17-60% of the female population, and it is one of the most common chronic diseases. Incontinence substantially decreases the quality of patients' lives. The transobturator tape (TOT) procedure is the gold standard in surgical treatment due to its high efficacy and low complication rate. The aim of this study was to assess the quality of life (QoL) of patients with stress incontinence before and after the TOT procedure. The study included 57 patients diagnosed with stress incontinence on the basis of ultrasonography and history. The QoL before and after surgery was measured using the Incontinence Impact Questionnaire (IIQ-7) and the Incontinence Quality of Life (I-QOL) standardised questionnaires. The IIQ-7 scores for each question were higher (indicating poorer quality of life) before surgery than after surgery. The results for almost all domains were statistically significant. The I-QOL results also showed that, in most cases, the quality of patients' lives improved after the surgery. Statistically significant changes were observed in all three questionnaire domains of avoidance/limiting behaviour, psychosocial impact, and social embarrassment. Surgical treatment of stress incontinence with TOT results in resolution of bothersome symptoms in the majority of patients, leading to improved comfort in life.
Sections du résumé
BACKGROUND
BACKGROUND
Urinary incontinence (UI) is a significant social problem. The latest figures show that it affects as many as 17-60% of the female population, and it is one of the most common chronic diseases. Incontinence substantially decreases the quality of patients' lives. The transobturator tape (TOT) procedure is the gold standard in surgical treatment due to its high efficacy and low complication rate.
OBJECTIVE
OBJECTIVE
The aim of this study was to assess the quality of life (QoL) of patients with stress incontinence before and after the TOT procedure.
METHOD
METHODS
The study included 57 patients diagnosed with stress incontinence on the basis of ultrasonography and history. The QoL before and after surgery was measured using the Incontinence Impact Questionnaire (IIQ-7) and the Incontinence Quality of Life (I-QOL) standardised questionnaires.
RESULTS
RESULTS
The IIQ-7 scores for each question were higher (indicating poorer quality of life) before surgery than after surgery. The results for almost all domains were statistically significant. The I-QOL results also showed that, in most cases, the quality of patients' lives improved after the surgery. Statistically significant changes were observed in all three questionnaire domains of avoidance/limiting behaviour, psychosocial impact, and social embarrassment.
CONCLUSION
CONCLUSIONS
Surgical treatment of stress incontinence with TOT results in resolution of bothersome symptoms in the majority of patients, leading to improved comfort in life.
Identifiants
pubmed: 34640588
pii: jcm10194571
doi: 10.3390/jcm10194571
pmc: PMC8509480
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Health Qual Life Outcomes. 2014 Aug 30;12:133
pubmed: 25174274
Int Urogynecol J. 2012 Jul;23(7):843-9
pubmed: 22527558
Taiwan J Obstet Gynecol. 2019 Jan;58(1):94-98
pubmed: 30638489
J Family Reprod Health. 2014 Mar;8(1):13-9
pubmed: 24971128
Neurourol Urodyn. 2017 Apr;36(4):909-914
pubmed: 28444705
Rev Bras Ginecol Obstet. 2016 Feb;38(2):97-111
pubmed: 26883864
BJU Int. 2007 Mar;99(3):601-5
pubmed: 17155988
Eur Urol. 2010 Aug;58(2):218-38
pubmed: 20434257
BJOG. 2005 Jul;112(7):971-6
pubmed: 15958002
Ther Clin Risk Manag. 2018 Nov 20;14:2293-2303
pubmed: 30538485
Urologe A. 2020 Jan;59(1):65-71
pubmed: 31741004
Int Urogynecol J Pelvic Floor Dysfunct. 2009 May;20(5):575-9
pubmed: 19209375
Int J Gynaecol Obstet. 2003 Sep;82(3):327-38
pubmed: 14499979
Prz Menopauzalny. 2019 Apr;18(1):46-50
pubmed: 31114458
Qual Life Res. 2006 Apr;15(3):493-501
pubmed: 16547788
BJU Int. 2016 Jan;117(1):20-33
pubmed: 26033093
Neurourol Urodyn. 2009;28(8):976-81
pubmed: 19229955
Przegl Epidemiol. 2012;66(3):539-45
pubmed: 23230728
BJU Int. 2006 Jan;97(1):96-100
pubmed: 16336336
Taiwan J Obstet Gynecol. 2018 Aug;57(4):528-531
pubmed: 30122572
Prog Urol. 2017 Mar;27(3):111-145
pubmed: 28284822
Am J Obstet Gynecol. 2001 Dec;185(6):1332-7; discussion 1337-8
pubmed: 11744905
N Engl J Med. 2010 Jun 3;362(22):2066-76
pubmed: 20479459
BJU Int. 2004 Jun;93(9):1246-52
pubmed: 15180616
Zhonghua Fu Chan Ke Za Zhi. 2014 Oct;49(10):754-7
pubmed: 25537247
Qual Life Res. 2005 Oct;14(8):1901-13
pubmed: 16155777
Maturitas. 2011 Feb;68(2):137-42
pubmed: 21195563